
Helga Helseth Hektoen
- Post doc; PhD
MSc in chemistry with a specialization in cancer epidemiology from the Cancer Registry of Norway, experienced in analyzing national real-world data, with a focus on immunotherapy and survival outcomes in non-small cell lung cancer.
Currently working with the project: Impact of commonly prescribed non-oncology drugs on immunotherapy outcomes.